Active ingredientEthionamideCat. No. P-E118-001CAS 536-33-4Family · Pharmaceutical analytical standards
Ethionamide
An antituberculosis drug of the thioamide family, discovered in 1956 and approved in the United States in 1965: it is used for multidrug-resistant tuberculosis and is on the WHO List of Essential Medicines. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It is a prodrug: it is activated by an enzyme of Mycobacterium tuberculosis itself, EthA, and once active it blocks the enzyme InhA, the same target as isoniazid.
Go to the active ingredient →Active ingredientEthionamideCat. No. P-E118-001CAS 536-33-4
Pharmacopoeial impurityEthionamide EP Impurity BCat. No. P-E118-002CAS 100-48-1
Isotopically labelledEthionamide-d3Cat. No. P-E118-003CAS 2748267-66-3
Impurity2-EthylisonicotinamideCat. No. P-E118-005CAS 3376-95-2
Impurity2-Methylpyridine-4-carbothioamideCat. No. P-E118-006CAS 3390-77-0
Impurity4-ThioisonicotinicamideCat. No. P-E118-007CAS 2196-13-6
ImpurityEthionamide SulfoxideCat. No. P-E118-008CAS 536-28-7No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceEthionamide CRSEDQM code E2000000Family EthionamideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.